The late Dr. Saul Hertz’s prediction that a targeted radionuclide approach “would hold the key to the larger problem of ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

A consensus statement published in Endocrine Practice examines how health care professionals should approach treating and ...

(NEPC). The findings enhance the understanding of the treatment of androgen receptor functions in NEPC. Neuroendocrine prostate cancer (NEPC) arises primarily through neuroendocrine ...

The incidence of pancreatic adenocarcinoma increases across all age groups, whereas colorectal adenocarcinoma increases only among younger age groups.

Neurosurgery experts from UCSF Health will present new research and clinical findings at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Boston, April 25-28.

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...

The following is a summary of “Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients ...

Sunshine Biopharma (SBFM) announced that its wholly owned Canadian subsidiary, Nora Pharma, has launched Everolimus in the Canadian generic ...

In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumour growth. Merkel cell carcinoma is a rare but fast-growing neuroendocrine cancer that is three to five times more likely than ...